D2 dopamine receptor and GABA(A) receptor β3 subunit genes and alcoholism

Psychiatry Research

Volumn 81, Issue 2, 1998, Pages 133-147

  Noble, Ernest P ^a   Zhang, Xuxian ^a   Ritchie, Terry ^a   Lawford, Bruce R ^b   Grosser, Stella C ^a   Young, Ross McD ^b   Sparkes, Robert S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Alcoholism; Association analysis; DRD2; GABA(A) 3; Genetics; Severity

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; DOPAMINE 2 RECEPTOR; RECEPTOR SUBUNIT;

ADULT; ALCOHOLISM; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; FEMALE; GABAERGIC SYSTEM; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RECEPTOR GENE; ALLELE; AUSTRALIA; BIOLOGICAL MODEL; CLASSIFICATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; MIDDLE AGED; PROGNOSIS; RISK;

ADULT; ALCOHOLISM; ALLELES; AUSTRALIA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; PROGNOSIS; RECEPTORS, DOPAMINE D2; RECEPTORS, GABA-A; RISK; VARIATION (GENETICS);

EID: 0032538657     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(98)00084-5     Document Type: Article

References (107)

1. Agresti, A., 1984. Analysis of Ordinal Categorical Data. John Wiley and Sons, New York, pp. 112-116.
2. Allan, A.M., Harris, R.A., 1991. Neurochemical studies of genetic differences in alcohol action. In: Crabbe, J.C., Jr., Harris, R.A. (Eds.), The Genetic Basis of Alcohol and Drug Actions. Plenum Press, New York, pp. 105-152.
3. 2 receptor gene is associated with schizophrenia. Human Molecular Genetics. 6:1997;577-582.
4. Babor T.F., Hofman M., DelBoca F.K., Hesselbrock V., Meyer R.E., Dolinsky Z.S., Rounsaville B. Types of alcoholics, I: Evidence for an empirically derived typology based on indicators of vulnerability and severity. Archives of General Psychiatry. 49:1992;599-608.
5. Bell D.A., Taylor J.A. [letter]. Genetic analysis of complex diseases. Science. 275:1997;1327-1328.
6. 2 receptor gene in alcoholism. Journal of the American Medical Association. 263:1990;2055-2060.
7. 2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behavior. Pharmacogenetics. 5:1995;121-141.
8. 2 receptor gene and alcoholism. Journal of the American Medical Association. 264:1990;3156-3160.
9. Braun, W.E., 1979. HLA and Disease. CRC Press, Boca Raton, FL.
10. Cambien F., Poirer O., Lecerf L., Evans A., Cambou J.-P., Arveiler D., Luc G., Bard J.-M., Bara L., Ricard S., Tiret L., Amouyel P., Alhenc-Gelas F., Soubrierm F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
11. Carswell S., Alwine J.C. Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences. Molecular and Cellular Biology. 9:1989;4248-4258.
12. Cloninger C.R. Neurogenetic adaptive mechanisms in alcoholism. Science. 236:1987;410-416.
13. 2 dopamine receptor gene is associated but not linked with alcoholism. Journal of the American Medical Association. 266:1991;1833-1834.
14. Cloninger C.R., Bohman M., Sigvardsson S. Inheritance of alcohol abuse. Archives of General Psychiatry. 38:1981;861-868.
15. 2 test. Biometrics. 10:1954;417-451.
16. Comings D.E. Why different rules are required for polygenic inheritance: lessons from studies of the DRD2 gene. Alcohol. 16:1998;61-70.
17. 2 receptor locus as a modifying gene in neuropsychiatric disorders. Journal of the American Medical Association. 266:1991;1793-1800.
18. 2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics. 6:1996;73-79.
19. 2 receptor gene: a genetic risk factor in substance abuse. Drug and Alcohol Dependence. 34:1994;175-180.
20. Comings D.E., Wu S., Chiu C., Ring R.H., Gade R., Ahn C., MacMurray J.P., Dietz G., Muhleman D. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit-hyperactivity, conduct and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes DRD2, DβH and DAT1. American Journal of Medical Genetics. 67:1996;264-288.
21. 2 dopamine receptor gene and alcoholism: a genetic effect on liability for alcoholism. Journal of the Royal Society of Medicine. 87:1994;400-402.
22. Cooper D.N. Regulatory mutations and human genetic disease. Annals of Medicine. 24:1992;427-437.
23. Corder E.H., Saunders A.M., Risch N.J., Strittmatter M.J., Schmechel D.E., Gaskil P.C. Jr., Rimmler J.B., Locke P.A., Conneally P.M., Schmaderk K.E., Small G.W., Roses A.D., Haines J.L., Pericak-Vance A. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics. 7:1994;180-184.
24. Culiat C.T., Stubbs L.S., Montgomery C.S., Russell L.B., Rinchik E.M. Phenotypic consequences of the deletion of the γ3, α5, or β3 subunit of the type A γ-aminobutyric acid receptor in mice. Proceedings of the National Academy of Sciences USA. 91:1994;2815-2818.
25. Culiat C.T., Stubbs L.J., Woychik R.P., Russell L.B., Johnson D.K., Rinchik E.M. Deficiency of the β3 subunit of the type A γ-aminobutyric acid receptor causes cleft palate in mice. Nature Genetics. 11:1995;344-346.
26. Deitrich R.A., Dunwiddie T.V., Harris A.R., Erwin V.G. Mechanisms of action of ethanol: initial central nervous system action. Pharmacological Reviews. 41:1989;489-537.
27. A receptor have a role to play in Angelman syndrome? In: Tanaka, C., Bowery, N. (Eds.), GABA Receptors, Transporters and Metabolism. Basel, Birkhäuser, pp. 275-282.
28. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving animals. Proceedings of the National Academy of Sciences USA. 85:1988;5274-5278.
29. 2 dopamine receptor and neuronal cell adhesion molecule genes in human chromosome 11q23. Genomics. 14:1992;1010-1018.
30. Evans L.J. Effect of genetic architecture on the power of human linkage studies to resolve the contribution of quantitative trait loci. Heredity. 72:1994;175-192.
31. Fadda F., Argiolas A., Melis M.R., DeMontis G., Gessa G.L. Suppression of voluntary ethanol consumption in rats by gammabutyrolactone. Life Sciences. 32:1983;1471-1477.
32. Frye G.D., Breese G.R. GABAergic modulation of ethanol-induced motor impairment. Journal of Pharmacology and Experimental Therapeutics. 223:1982;750-756.
33. 2 receptor gene in alcoholism or schizophrenia. Journal of the American Medical Association. 271:1994;204-208.
34. 2 dopamine receptor gene and alcoholism. Journal of the American Medical Association. 269:1993;1673-1677.
35. 2 dopamine receptor gene (DRD2) and alcoholism. Journal of the American Medical Association. 266:1991;1801-1807.
36. Glatt K., Glatt H., Lalande M. Structure and organization of GABRB3 and GABRA5. Genomics. 41:1997;63-69.
37. Goldman, D., 1993. Genetic transmission. In: Galanter, M. (Ed.), Recent Developments in Alcoholism, vol. 11, Ten Years of Progress. Plenum Press, New York, pp. 232-248.
38. Goodwin D.W. Alcoholism and heredity. Archives of General Psychiatry. 36:1981;57-61.
39. Gorwood P., Ades J., Feingold J. Are genes coding for dopamine receptors implicated in alcoholism? European Psychiatry. 9:1994;63-69.
40. 2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. American Journal of Human Genetics. 45:1989;778-785.
41. Grandy D.K., Zhang Y., Civelli O. PCR detection of the TaqI A RFLP at the DRD2 locus. Human Molecular Genetics. 2:1993;2197.
42. Greger V., Knoll J.H.M., Woolf E., Glatt K., Tyndale R.F., DeLorey T.M., Olsen R.W., Tobin A.J., Sikela J.M., Nakatsu Y., Brilliant M.H., Whiting P.J., Lalande M. The γ-aminobutyric acid receptor γ3 subunit gene (GABRG3) is tightly linked to the α5 subunit gene (GABRA5) on human chromosome 15q11-q13 and is transcribed in the same orientation. Genomics. 26:1996;258-264.
43. Hellevuo K., Kiianmaa K., Korpi E.R. Effect of GABAergic drugs on motor impairment from ethanol, barbital and lorazepam in rat lines selected for differential sensitivity to ethanol. Pharmacology, Biochemistry and Behavior. 34:1989;399-404.
44. Hodge C.W., Chappelle A.M., Samson H.H. GABAergic transmission in the nucleus accumbens is involved in the termination of ethanol self-administration in rats. Alcoholism, Clinical and Experimental Research. 19:1995;1486-1493.
45. Homanics G.E., DeLorey T.M., Firestone L.L., Quinlan J.J., Handforth A., Harrison N.L., Krasowski M.D., Rick C.E.M., Korpi E.R., Mäkelä R., Brilliant M.H., Hagiwara N., Ferguson C., Snyder K., Olsen R.W. Mice devoid of γ-aminobutyrate type A receptor β3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proceedings of the National Academy of Sciences USA. 94:1997;4143-4148.
46. Hwang B.H., Lumeng L., Wu J.Y., Li T.-K. Increased number of GABAergic terminals in the nucleus accumbens is associated with alcohol preference in rats. Alcoholism, Clinical and Experimental Research. 14:1990;503-507.
47. Kendler K.S., Neale M.C., Heath A.C., Kessler R.C., Eaves L.T. A twin-family study of alcoholism in women. American Journal of Psychiatry. 151:1994;707-715.
48. Kidd, J.R., Pakstis, A.J., Kidd, K.K., 1993. Global Levels of DNA Variation. Proceedings of the 4th International Symposium on Human Identification. Promega, Madison, pp. 21-30.
49. Kirkness E.F., Fraser C.M. A strong promoter element is located between alternative exons of a gene encoding the human γ-aminobutyric acid-type A receptor β3 subunit (GABRB3). Journal of Biological Chemistry. 268:1993;4420-4428.
50. Koob G.F. Drugs of abuse. Anatomy, pharmacology and function of reward pathways. Trends in Pharmacological Sciences. 13:1992;177-184.
51. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
52. Koob G.F., Mendelson W.B., Schaffer J., Wall T.L., Britton K.T., Bloom F.E. Picrotoxinin receptor ligand blocks anti-punishment effects of alcohol. Alcohol. 5:1988;437-443.
53. Lander E.S., Schork N.J. Genetic dissection of complex traits. Science. 265:1994;2037-2048.
54. A receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. Journal of Neuroscience. 12:1992;4151-4172.
55. 2 dopamine receptor A1 allele with alcoholism: medical severity of alcoholism and type of control. Biological Psychiatry. 41:1997;386-393.
56. 2 dopamine receptor A1 allele. Nature Medicine. 1:1995;337-341.
57. A receptor function: molecular and physiological determinants. Advances in Biochemical Psychopharmacology. 47:1992;269-279.
58. Liljequist S., Engel T. Effects of GABAergic agonists and antagonists on various ethanol-induced behavioral changes. Psychopharmacology. 78:1982;71-77.
59. Liljequist S., Engel J.A. The effects of GABA and benzodiazepine receptor antagonists in the anti-conflict actions of diazepam or ethanol. Pharmacology, Biochemistry and Behavior. 21:1984;521-525.
60. Long A.D., Grote M.N., Langley C.H. [letter]. Genetic analysis of complex diseases. Science. 275:1997;1328.
61. McBride W.J., Murphy J.M., Lumeng L., Li T.-K. Effects of RO-15-4513, fluoxetine and desipramine on the intake of ethanol, water and food by the alcohol-preferring (P) and non-preferring (NP) lines of rats. Pharmacology, Biochemistry and Behavior. 30:1988;1045-1050.
62. A-receptor subtypes really occur in the brain? Trends in Neuroscience. 19:1996;139-143.
63. 2 receptors. Nature. 388:1997;586-589.
64. Macdonald R.L., Olsen R.W. GABAA receptor channels. Annual Review of Neuroscience. 17:1994;569-602.
65. Minassian B.A., DeLorey T., Olsen R., Bryanat A., Homanics G., Firestone L., Skinner S., Handforth A., Asataourian A., Delgado-Escueta A. GABRB3: a gene involved in epilepsy of Angelman Syndrome (AS). American Journal of Human Genetics. 59(#4suppl):1996;A273.
66. A receptor β3 (GABRB3) locus in the Angelman/Prader-Willi region (AS/PWS) of chromosome 15. Human Molecular Genetics. 1:1992;67.
67. Nakatsu Y., Tyndale R.F., DeLorey T.M., Durham-Pierce D., Gardner J.M., McDanel H.J., Nguyen Q., Wagstaff J., Lalande M., Sikela J.M., Olsen R.W., Tobin A.J., Brilliant M.H. A cluster of three GABA receptor subunit genes is deleted in a neurological mutant of the mouse p locus. Nature. 364:1993;448-450.
68. National Institute on Alcohol Abuse and Alcoholism, Alcohol and Health, 1997. Ninth Special Report to the US Congress, US Department of Health and Human Services, pp. 43-45.
69. 2 receptor gene in samples of female and male alcoholics. American Journal of Medical Genetics. 60:1995;267-271.
70. Neiswanger K., Kaplan B.B., Hill S.Y. An editorial: what can the DRD2/alcoholism story teach us about association studies in psychiatric genetics? American Journal of Medical Genetics. 60:1995;272-275.
71. Noble E.P. Alcoholism and the dopaminergic system: a review. Addiction Biology. 1:1996;333-348.
72. Noble E.P. The gene that rewards alcoholism. Scientific American Science and Medicine. 3(#2):1996;52-61.
73. 2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes. Alcohol. 16:1998;33-45.
74. 2 receptor gene [letter]. Journal of the American Medical Association. 270:1993;1547.
75. 2 dopamine receptor gene with cocaine dependence. Drug and Alcohol Dependence. 33:1993;271-285.
76. 2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Archives of General Psychiatry. 48:1991;648-654.
77. 2 dopamine receptor gene and obesity. International Journal of Eating Disorders. 15:1994;205-217.
78. 2 dopamine receptor gene and cigarette smoking: a reward gene? Medical Hypotheses. 42:1994;257-260.
79. 2 dopamine receptor TaqI A alleles in medically ill alcoholic and nonalcoholic patients. Alcohol and Alcoholism. 29:1994;729-744.
80. 2 receptor RFLPs, haplotypes and their association with substance use in Black and Caucasian research volunteers. Human Heredity. 43:1993;209-218.
81. Ott J. A chi-square test to distinguish allelic association from other causes of phenotypic association between two loci. Genetic Epidemiology. 2:1985;79-84.
82. A receptor α1 and α3 subunit genes and alcoholism. Alcoholism, Clinical and Experimental Research. 21:1997;430-433.
83. 2 dopamine receptor locus: studies of association and linkage. Archives of General Psychiatry. 48:1991;655-663.
84. 2 receptor and alcoholism: a meta-analysis. American Journal of Medical Genetics. 48:1993;78-82.
85. Pickens R.W., Svikis D.S., McGue M., Lykken D.T., Heston L.L., Clayton P.J. Heterogeneity in the inheritance of alcoholism: A study of male and female twins. Archives of General Psychiatry. 48:1991;19-28.
86. Plomin R. The role of inheritance in behavior. Science. 248:1990;183-186.
87. Plomin R., Owen M.J., McGuffin P. The genetic basis of complex human behaviors. Science. 264:1994;1733-1739.
88. 2 receptor availabilitiy in healthy controls. Molecular Psychiatry. 3:1998;256-260.
89. Rassnick S., D'Amico E., Riley E., Koob G.F. GABA antagonist and benzodiazepine partial inverse agonist reduce motivated responding for ethanol. Alcoholism, Clinical and Experimental Research. 17:1993;124-130.
90. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517.
91. Rothman, K.J., Greenland, S., 1998. Modern Epidemiology, 2nd ed. Lippincott-Raven, Philadelphia, pp. 227-228.
92. Rotondaro L., Mele A., Rovera G. Efficacy of different viral promoters in directing gene expression in mammalian cells: effect of 3′-untranslated sequences. Gene. 168:1996;195-198.
93. Schächter F., Faure-Delanef L., Guénot F., Rouger H., Froquel P., Lesueur-Ginot L., Cohen D. Genetic association with human longevity at APOE and ACE loci. Nature Genetics. 6:1994;29-32.
94. Schunkert H., Hense H.-W., Holmer S.R., Stender M., Perz S., Keil U., Lorell B.H., Riegger G.A. Association between a detection polymorphism of the angiotensin-converting enzyme and left ventricular hypertrophy. New England Journal of Medicine. 330:1994;1634-1638.
95. Smith S.S., O'Hara B.F., Persico A.M., Gorelick D.A., Newlin D.B., Vlahov D., Solomon L., Pickens R., Uhl G.R. Genetic vulnerability in polysubstance abusers. Archives of General Psychiatry. 49:1992;723-727.
96. 2 dopamine receptor gene and smoking status in lung cancer. Journal of the National Cancer Institute. 90:1998;358-363.
97. Stephenson F.A. The GABAA receptors. Biochemistry Journal. 310:1995;1-9.
98. Suzdak P.D., Glowa J.R., Crawley J.N., Schwartz R.D., Skolnick P., Paul S.M. A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science. 234:1986;1243-1247.
99. Thompson J., Thomas N., Singleton A., Piggott M., Lloyd S., Perry E.K., Morris C.M., Perry R.H., Ferrier I.N., Court J.A. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics. 7:1997;479-484.
100. Trepicchio W.L., Krontiris T.G. Members of the rel/NF-κB family of transcriptional regulatory factors bind the HRAS1 minisatellite DNA sequence. Nucleic Acids Research. 25:1992;2427-2434.
101. 2 dopamine receptor (DRD2) gene in a British Caucasian control group screened to exclude alcoholism and heavy drinking. Addiction Biology. 2:1997;207-213.
102. 2 receptor gene. Trends in Neuroscience. 16:1993;83-88.
103. Van Heuvel M., Bosveld I.J., Trapman J., Zwarthoff E.C. Transient expression of murine interferon-alpha genes in mouse and monkey cells. Gene. 45:1986;158-165.
104. A receptor β3 subunit to the Angelman/Prader-Willi region of human chromosome 15. American Journal of Human Genetics. 49:1991;330-337.
105. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. Journal of Neuroscience. 12:1992;1040-1062.
106. Wise R.A. Neurobiology of addiction. Current Opinion in Neurobiology. 6:1996;243-251.
107. Wise R.A., Rompre P.P. Brain dopamine and reward. Annual Review of Psychology. 40:1989;191-225.